Alnylam garners $10M RNAi payment; Actelion warns investors on Elliott ploy;

 @FierceBiotech:  Cancer drug developer MethylGene raises $34.5M. Story | Follow @FierceBiotech 

 @JohnCFierce: Americans pay $4,000 a month for Gilenya, Germans $2,620. I wonder how much Yervoy will cost in Europe. Article | Follow @JohnCFierce 

> Alnylam landed a $10 million payment from Takeda, part of its milestone schedule based on their RNAi partnership. Alnylam says that it has raked in $140 million from its deal to transfer RNAi tech to the Japanese pharma company. Report

> Actelion sent out an alarm to investors Monday, claiming that Elliott Advisers are only interested into forcing the company into a quick sale. Elliott has been mounting a fight to gain control of the company as it advocates for a change of direction. Story

> Shares of the UK's Allergy Therapeutics have been buoyed by the news that the FDA has lifted the clinical hold on its program for pollen allergy. Report

> Spectrum Pharmaceuticals says an independent monitoring board has given its blessing on a pivotal study of belinostat, an experimental lymphoma therapy. Spectrum intends to seek a rolling review of the drug over the next two years. Story

Pharma News

@FiercePharma: Does Steere's exit signal a new day at Pfizer? News | Follow @FiercePharma

> More family-medicine programs exclude pharma. Article

> Pfizer, Genentech and APP initiate recalls. Report

> Chinese government slashes drug prices by 21%. News

> AZ to pay $1.1B in better-than-expected tax deal. Article

> With $120K price tag, Yervoy hailed as potential blockbuster. Story

Biotech IT News

> At Partnerships, proactive medical monitoring for adaptive trials. Editor's Corner

> Orthopedic imaging network aids subject recruitment. Article

> Database gives Rochester Clinical a recruitment boost. Report

> Product Update: Symyx Notebook 6.6. Item

> Inference engine, EDC team to ID trial volunteers. Item

> Biomarker tool pilots cancer drugs into clinic. Article

Medical Device News

> Report: AstraZeneca reviewing bids for AstraTech. News

> J&J's Ethicon unit voluntarily recalls wound draining products. Story

> Medtronic gets good news on Consulta, Syncra CRT-P systems. Item

> UCSF, UC Berkeley team on brain repair devices. Article

> Tethys, Air Force to collaborate on PreDx study. Article

> Elana gets humanitarian device exemption for bypass device. Report

And Finally... Music and laughter deliver a statistically significant reduction in blood pressure-compared to the no-music, no-laughter cohort. Story